Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001213900-25-002719
Filing Date
2025-01-10
Accepted
2025-01-10 17:00:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 26961
  Complete submission text file 0001213900-25-002719.txt   28531
Mailing Address 3651 LINDELL RD STE D131 LAS VEGAS NV 89103
Business Address
Goodman Anthony Brian (Filed by) CIK: 0001672837 (see all company filings)

Type: SCHEDULE 13D

Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Subject) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-90013 | Film No.: 25523759
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)